Results 21 to 30 of about 94,200 (277)

Effect of Vitamin E on oxaliplatin-induced peripheral neuropathy prevention: A randomized controlled trial

open access: yesInternational Journal of Preventive Medicine, 2015
Background: Peripheral neuropathy is one of the most important limitations of oxaliplatin base regimen, which is the standard for the treatment of colorectal cancer.
Zeinab Salehi, Mahnaz Roayaei
doaj   +1 more source

Risk factors for paclitaxel-induced peripheral neuropathy in patients with breast cancer

open access: yesBMC Cancer, 2018
Background Paclitaxel induced peripheral neuropathy (PIPN) is a major debilitating side effect of paclitaxel in patients with breast cancer with no fully known mechanisms. The aim of the study was to find out the possible risk factors for PIPN.
Zohreh Ghoreishi   +5 more
doaj   +1 more source

Neoplastic Parkinsonism: An illustrative case report

open access: yesAnnals of Indian Academy of Neurology, 2013
Non-Hodgkin′s lymphoma of T-cell types are rare neoplasms. Central nervous system metastasis is unusual. We are reporting a patient with peripheral T-cell lymphoma unspecified who had extra nodal metastasis into the brain that manifested with ...
Lekha Pandit   +4 more
doaj   +1 more source

The GDNF Family: A Role in Cancer?

open access: yesNeoplasia: An International Journal for Oncology Research, 2018
The glial cell line–derived neurotrophic factor (GDNF) family of ligands (GFLs) comprising of GDNF, neurturin, artemin, and persephin plays an important role in the development and maintenance of the central and peripheral nervous system, renal ...
Graeme C. Fielder   +7 more
doaj   +1 more source

Somatostatin and Its Receptor System in Colorectal Cancer

open access: yesBiomedicines, 2021
Somatostatin (SST)/somatotropin release-inhibiting factor (SRIF) is a well-known neuropeptide, widely distributed in the central and peripheral nervous systems, that regulates the endocrine system and affects neurotransmission via interaction with five ...
Aldona Kasprzak
doaj   +1 more source

Liver Transplantation for Alagille's Syndrome [PDF]

open access: yes, 1993
Twenty-three children with Alagille's syndrome and end-stage liver disease underwent liver transplantation with cyclosporine and low-dose steroid immunosuppression. Two to 9 years (mean, 4.4 years) after surgery, 13 (57%) of the children were still alive,
Reyes, J   +5 more
core   +1 more source

Impact of Human Immunodeficiency Virus in the Pathogenesis and Outcome of Patients with Glioblastoma Multiforme. [PDF]

open access: yes, 2016
BackgroundImprovement in antiviral therapies have been accompanied by an increased frequency of non-Acquired Immune Deficiency Syndrome (AIDS) defining malignancies, such as glioblastoma multiforme.
Bui, Timothy T   +5 more
core   +1 more source

Tumors in von Hippel–Lindau Syndrome: From Head to Toe—Comprehensive State-of-the-Art Review [PDF]

open access: yes, 2018
Von Hippel–Lindau syndrome (VHL) is an autosomal-dominant hereditary tumor disease that arises owing to germline mutations in the VHL gene, located on the short arm of chromosome 3.
Bhalla, Sanjeev   +6 more
core   +1 more source

Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms [PDF]

open access: yes, 2018
We analyzed 597 patients with myeloproliferative neoplasms (MPN) who presented transient ischemic attacks (TIA, n = 270) or ischemic stroke (IS, n = 327). Treatment included aspirin, oral anticoagulants, and cytoreductive drugs.
Arellano-Rodrigo, Eduardo   +41 more
core   +5 more sources

Impact of primary organ site of involvement by peripheral T‐cell lymphoma not otherwise specified on survival

open access: yesCancer Medicine, 2023
Introduction Peripheral T‐cell lymphoma, not otherwise specified (PTCL‐NOS) is a rare, highly heterogeneous group of mature T‐cell neoplasms that historically has been associated with poor outcomes.
Olivia Davis   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy